AMRECIBART
UNII ZDR9VW2WMN

Substance Identification & Data

This profile provides standardized clinical and technical data for Amrecibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZDR9VW2WMN.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3008610-20-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZDR9VW2WMN

CAS Registry Number

3008610-20-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

AMRECIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C214499

National Cancer Institute reference terminology for clinical and research data.

INN ID

13412

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

OP-129

Identifier assigned by the United States Adopted Names Council.

Substance Type

Amrecibart

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Amrecibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

Amrecibart

Common Names & Synonyms

AMRECIBART [USAN]

Immunoglobulin G4 [231-proline], anti-(human blood-coagulation factor XI) (human monoclonal REGN9933 γ4-chain), disulfide with human monoclonal REGN9933 κ-chain, dimer

Immunoglobulin G4 [231-proline], anti-(human blood-coagulation factor XI) (human monoclonal REGN9933 γ4-chain), disulfide with human monoclonal REGN9933 κchain, dime

Immunoglobulin G4-kappa, anti-[Homo sapiens F11 (coagulation factor 11, coagulation factor XI, FXI, plasma thromboplastin antecedent, PTA)], Homo sapiens monoclonal antibody; H-gamma4 heavy chain Homo sapiens (1-450) [VH (Homo sapiens IGHV3-23*03 (91.8%) -(IGHD) -IGHJ3*02 (100%), CDR-IMGT [8.8.16] (26-33.51-58.97-112)) (1-123) -Homo sapiens IGHG4*01, nG4m(a) CH2 L92, 12-G4v5 h P10(CH1 (124-221), hinge 1-12 S10>P (231) (222-233), CH2 L92 (312) (234-343), CH3 (344-448), CHS (449-450)) (124-450)], (137-215')-disulfide with L-kappa light chain Homo sapiens (1'-215') [V-KAPPA (Homo sapiens IGKV1-39*01 (100%) -IGKJ5*01 (100%), CDR-IMGT [6.3.10] (27'-32'.50'-52'.89'-98')) (1'-108') - Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (154'), V101 (192')) (109'-215')]; dimer (229-229'':232-232'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa

amrecibart [INN]